Literature DB >> 7105043

Heterogeneity of the growth and metastatic behavior of cloned cell lines derived from a primary rhabdomyosarcoma.

F L Sweeney, J Pot-Deprun, M F Poupon, I Chouroulinkov.   

Abstract

In order to study the heterogeneity of the metastatic and tumorigenic behaviors of malignant neoplasms, we have isolated a series of cloned cell lines from a primary nickel-induced rat rhabdomyosarcoma. The growth characteristics in vitro and in vivo and metastatic capacity following s.c. or i.v. injection of cells were compared to those of the parental cell line. Differences between the cloned cell lines themselves and between the clones and the parental cells were found in the number of metastases provoked by both i.v. and s.c. injections, in the number of cells required to induce s.c. tumors, and in the growth rate of those tumors. In vitro, the doubling times and saturation densities of the different cell lines varied greatly. A direct correlation was observed between the 50% tumoral dose and the initial tumor growth phase. We found that there was a tendency for lines which were highly metastatic after s.c. injection to have a low metastatic capacity after i.v. injection and inversely. The two types of metastasis (spontaneous and experimental) appear therefore to depend on different characteristics of the cells used.

Entities:  

Mesh:

Year:  1982        PMID: 7105043

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Spontaneous but not experimental metastatic activities differentiate primary tumor-derived vs metastasis-derived mouse prostate cancer cell lines.

Authors:  S J Hall; T C Thompson
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

Review 2.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

3.  Biological heterogeneity and radiation sensitivity of in vitro propagated lung metastatic lines originated from a transplantable squamous cell carcinoma of BALB/c mouse.

Authors:  R J Jamasbi; E H Perkins
Journal:  In Vitro Cell Dev Biol       Date:  1990-03

4.  Effects of glycosaminoglycans and extracellular matrix components on metastatic rat rhabdomyosarcoma tumor and myoblast cell proliferation.

Authors:  F Redini; E Moczar; M F Poupon
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

5.  Antimetastatic effect of immunomodulators from Nocardia opaca in mice and rats activation of peritoneal macrophages by these fractions.

Authors:  R Barot-Ciorbaru; I Cornil; T Grand-Perret; M F Poupon
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

6.  The evolution of single cell-derived colorectal cancer cell lines is dominated by the continued selection of tumor-specific genomic imbalances, despite random chromosomal instability.

Authors:  Darawalee Wangsa; Rüdiger Braun; Madison Schiefer; Edward Michael Gertz; Daniel Bronder; Isabel Quintanilla; Hesed M Padilla-Nash; Irianna Torres; Cynthia Hunn; Lidia Warner; Floryne O Buishand; Yue Hu; Daniela Hirsch; Timo Gaiser; Jordi Camps; Russell Schwartz; Alejandro A Schäffer; Kerstin Heselmeyer-Haddad; Thomas Ried
Journal:  Carcinogenesis       Date:  2018-07-30       Impact factor: 4.944

Review 7.  Quantitative genetic analysis of tumor progression.

Authors:  V Ling; A F Chambers; J F Harris; R P Hill
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

8.  Failure of orally administered RA233 to influence B16 melanoma growth or metastasis.

Authors:  C W Stackpole; D M Fornabaio; A L Alterman
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

9.  Autoradiographic distribution of [14C]-labelled pimonidazole in rhabdomyosarcoma-bearing rats and pigmented mice.

Authors:  F Laurent; P Benard; P Canal; G Soula
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  Stimulation of natural killer cytotoxicity by long-term treatment with double-stranded polynucleotides without induction of hyporesponsiveness.

Authors:  D Nolibe; M N Thang
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.